Progress in Molecular Biology and Translational Science - 1st Edition - ISBN: 9780128177389

Progress in Molecular Biology and Translational Science, Volume 162

1st Edition

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A

Serial Volume Editors: Lijuan Zhang
Hardcover ISBN: 9780128177389
Imprint: Academic Press
Published Date: 1st April 2019
Page Count: 300
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Glycan-based Biomarkers for Diagnosis of Cancers and Other Diseases: Past, Present and Future
Minghui Hu
2. Desialylation in Diseases and its Application in Diagnostic and Therapeutic Development
Mohui Wei
3. Proteoglycans as Miscommunication Biomarkers for Cancer Diagnosis
Lingling Xu
4. Fucosylation in Cancer Biology and Its Clinical Applications
Ming Shan
5. Retrospective Analysis of Glycan-Related Biomarkers Based on Clinical Laboratory Data in Two Medical Centers during the Past Seven years
Meng Zhang
6. Serum SCCA Levels in Patients with Psoriasis, Cancers, or Other Diseases
Dandan Yang
7. Increased Serum CA724 Levels in Patients Suffering Gout vs. Cancers
Yiran Zhang
8. Serum CA50 Levels in Diagnosing Cancers and Other Diseases
Ming Shan
9. Fasting Blood Glucose Levels in Patients with different Types of Diseases
Qinghua Zhang
10. Serum AFP Levels are increased in Liver Cancer but Decreased in most types of Cancers and Diseases
Huaiqian Dou
11. Serum CEA Levels in 54 Different Types of Diseases
Cui Hao
12. CA242 as a Biomarker for Pancreatic Cancer and Other Diseases
Yanli He
13. Serum CA125 Levels are decreased in Colorectal Cancers but Increased in Most Types of Cancers
Meng Zhang
14. Serum CA199 level is significantly increased in patients suffering Liver Diseases
Pengjiao Zeng
15. CA15-3 as a Biomarker for Cancer and other Types of Diseases
Xiulian Li
16. Serum Glycated Albumin Level is Significantly Decreased in Patients with Different Types of Kidney Diseases
Zhe Wang
17. Glycated Serum Proteins: Higher Level as a Biomarker for Pancreatic Cancer and the Lower Level as a Biomarker for Leukemia
Xiaodan Huang
18. Higher HbAlc levels in Patients Suffering Pancreatitis
Zhifeng Jiang
19. Sialic Acid as a General Biomarker for all Types of Diseases
Xueling Wang
20. Combination of Different Glycan Biomarkers for Cancer Detection
Yang Tang
21. Serum α-L-fucosidase Levels are increased in all Types of Cancer Patients
Meng Zhang


Description

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A, Volume 162 in the Progress in Molecular Biology and Translational Science series provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include Glycan-based Biomarkers for Diagnosis of Cancers and Other Diseases: Past, Present and Future, Desialylation in Diseases and its Application in Diagnostic and Therapeutic Development, Proteoglycans as Miscommunication Biomarkers for Cancer Diagnosis, Fucosylation in Cancer Biology and Its Clinical Applications, Retrospective Analysis of Glycan-Related Biomarkers Based on Clinical Laboratory Data in Two Medical Centers, and many related topics.

Key Features

  • Includes comprehensive coverage of molecular biology
  • Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
  • Contains contributions from renowned experts in the field

Readership

Scientists working actively in the field, including those at levels ranging from graduate student to senior investigator. Volumes also are appropriate for new investigators to a field who wish to familiarize themselves with the latest work


Details

No. of pages:
300
Language:
English
Copyright:
© Academic Press 2019
Published:
Imprint:
Academic Press
Hardcover ISBN:
9780128177389

Ratings and Reviews


About the Serial Volume Editors

Lijuan Zhang Serial Volume Editor

Lijuan Zhang is a Professor of Translational Medicine at Ocean University of China. She completed her doctorates of biochemistry and molecular genetics at University of Alabama at Birmingham in 1995. Before then, she was a Fogarty International Fellow at NIH for three years studying glycan-based cancer biomarkers. She worked as post-doctorate fellow and research associate at both MIT and Harvard Medical School from 1995-2002. She joined the faculty of the Department of Pathology & Immunology at Washington University in St. Louis in 2002 as a tenure-tracked Assistant Professor. Her research had been focused on the biosynthesis, structures, and biological functions of glycans since 1985. Now her work is on translational aspects of glycans as biomarkers and therapeutics. She has over 60 peer reviewed publications. She edited and published a book entitled “Glycosaminoglycans in Development, Health, and Diseases” with the contributions of top scientists worldwide in 2010 by Elsevier.

Affiliations and Expertise

Ocean University of China, China